Colston Arthur Edgerton, MD

Dr. Pamela Morris is a graduate of Wellesley College and Duke University School of Medicine. She completed her internal medicine residency and cardiology fellowship at Duke Medical Center. She is Professor of Medicine in Cardiology and the Paul V. Palmer Chair of Cardiovascular Disease Prevention at the Medical University of South Carolina (MUSC). She serves as founder and director of The Seinsheimer Cardiovascular Health Program. Preventive cardiology has been a career-long interest for Dr. Morris. She has served as the medical director of the Duke University Preventive Approach to Cardiology (DUPAC) program (now the Duke Center for Living) and consultant to the Mayo Clinic Cardiovascular Health Program in Rochester, Minnesota. Dr. Morris currently provides comprehensive, integrated preventive care for patients referred with heart disease risk factors and for patients with established coronary heart disease. Dr. Morris is board-certified in internal medicine, cardiovascular diseases, and clinical lipidology (management of cholesterol disorders). She specializes in evaluation, diagnosis and management of patients with complex lipid abnormalities. Referrals are accepted for treatment strategies including nutrition, pharmacologic (drug) therapy, as well as LDL apheresis. Dr. Morris also specializes in the early detection of subclinical atherosclerosis and is experienced in assessment of coronary calcification and noninvasive angiography with cardiac CT. Dr. Morris is a fellow of the American College of Cardiology, the American Heart Association, the American Society for Preventive Cardiology, the European Society of Cardiology, and the National Lipid Association. She was the Chair of the American College of Cardiology Annual Scientific Sessions in 2021 and 2022 and is currently a Trustee on the Board of the American College of Cardiology. She remains a volunteer in the American Heart Association and has served on the AHA MidAtlantic Board of Directors, chairperson of the AHA Heart Walk, AHA Annual Gala, and the AHA Go Red for Women awareness campaign.

John Marcus Wharton, M.D. is professor of medicine with tenure at the Medical University of South Carolina in Charleston, South Carolina. Dr. Wharton received his M.D. from Vanderbilt University School of Medicine in Nashville, Tennessee, and completed an internship and residency at the University of California at San Francisco. He then completed his cardiology fellowship at Duke University Medical Center in Durham, North Carolina, and subsequently served as assistant professor of medicine, director of clinical cardiac electrophysiology, and associate professor of medicine with tenure there. Among his many awards and honors are the Albert Weinstein Prize in Medicine and the North American Society of Pacing and Electrophysiology (NASPE) Young Investigator Award. Dr. Wharton has published articles and abstracts in many journals, including the Journal of the American College of Cardiology, Pacing and Clinical Electrophysiology, and Circulation. He currently serves on the editorial board of EP Lab Digest, Clinical Cardiology, and the American Heart Journal. Dr. Wharton is a member of several scientific advisory committees, including the medical advisory panel at Boston Scientific, council of advisors at Medtronics, Inc. medical advisory board at Transurgical, Inc. and scientific committee of the European Society of Cardiology. He is also a member of several scholarly societies such as the Council of Clinical Cardiology, Cardiac Electrophysiology Society, and NASPE. Dr. Wharton serves on many educational committees including the NASPE training and fellowship committee, the NASPE task force of FDA atrial fibrillation ablation, and the American College of Chest Physicians panel on the management of atrial fibrillation in post-CABG patients. His primary research interests are aimed at catheter ablation of atrial fibrillation as well as other arrhythmias; he has lectured internationally on these topics.

Dr. Brian Houston is a cardiologist specializing in the management of advanced heart failure, including the care of patients before and after heart transplantation or left ventricular assist device (LVAD). After graduating from Emory University School of Medicine, Dr. Houston completed residency at Johns Hopkins Hospital in Baltimore, Maryland. He was invited to serve as an assistant chief of service of the Thayer Firm at Johns Hopkins Hospital, and he spent that year caring for patients and instructing residents and medical students. He remained at Johns Hopkins for his general cardiology fellowship and spent an additional year of fellowship there training in the care of advanced heart failure, LVADs, and transplantation. Dr. Houston has been invited to present his research work at international scientific meetings. He has a particular interest in cardiac sarcoidosis and in the effects of LVAD support on the gastrointestinal tract, blood, and the right side of the heart. He was honored to be named a finalist for the American Heart Association's Young Clinician Award in 2015. Dr. Houston believes that each patient with heart failure is unique and that, to live their best life, they require a caring and comprehensive approach from a dedicated medical team.